134 related articles for article (PubMed ID: 23581945)
1. The use, misuse and abuse of dabigatran.
Attia JR; Pearce R
Med J Aust; 2013 Apr; 198(7):356-7. PubMed ID: 23581945
[TBL] [Abstract][Full Text] [Related]
2. Is there really misuse and abuse of dabigatran?
Eikelboom JW; Hankey GJ
Med J Aust; 2013 Apr; 198(7):358-9. PubMed ID: 23581946
[No Abstract] [Full Text] [Related]
3. [Comparison of three methods of antithrombotic therapy in elderly patients with nonvalvular atrial fibrillation].
Shevelev VI; Kanorskiĭ SG
Kardiologiia; 2012; 52(7):56-60. PubMed ID: 22839715
[TBL] [Abstract][Full Text] [Related]
4. Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.
Eikelboom JW; Connolly SJ; Hart RG; Wallentin L; Reilly P; Oldgren J; Yang S; Yusuf S
J Am Coll Cardiol; 2013 Sep; 62(10):900-8. PubMed ID: 23770182
[TBL] [Abstract][Full Text] [Related]
5. Dabigatran: life-threatening bleeding.
Prescrire Int; 2013 Feb; 22(135):41-3. PubMed ID: 23444501
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in antithrombotic therapy for stroke prevention in patients with atrial fibrillation.
Lenchus JD
Hosp Pract (1995); 2013 Feb; 41(1):49-60. PubMed ID: 23466967
[TBL] [Abstract][Full Text] [Related]
7. Dabigatran, bleeding, and the regulators.
Moore TJ; Cohen MR; Mattison DR
BMJ; 2014 Jul; 349():g4517. PubMed ID: 25056265
[No Abstract] [Full Text] [Related]
8. The trouble with dabigatran.
Charlton B; Redberg R
BMJ; 2014 Jul; 349():g4681. PubMed ID: 25055830
[No Abstract] [Full Text] [Related]
9. Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis.
Ali A; Bailey C; Abdelhafiz AH
Age Ageing; 2012 Sep; 41(5):681-4. PubMed ID: 22378612
[TBL] [Abstract][Full Text] [Related]
10. Intermittent haemodialysis and continuous veno-venous dialysis are effective in mitigating major bleeding due to dabigatran.
Getta B; Muller N; Motum P; Hsu D; Zebeljan D; Rosenfeld D
Br J Haematol; 2015 May; 169(4):603-4. PubMed ID: 25425051
[No Abstract] [Full Text] [Related]
11. Atrial fibrillation and anticoagulation management: a wake-up call to practitioners, patients, and policymakers.
Fanikos J
J Med Econ; 2013 Oct; 16(10):1190-2. PubMed ID: 23919663
[No Abstract] [Full Text] [Related]
12. Concerns over data in key dabigatran trial.
Cohen D
BMJ; 2014 Jul; 349():g4747. PubMed ID: 25055831
[No Abstract] [Full Text] [Related]
13. Dabigatran "non-inferior" to warfarin, but only just.
BMJ; 2013 Feb; 346():f1219. PubMed ID: 23447339
[No Abstract] [Full Text] [Related]
14. [New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation].
Koziński M; Obońska K; Kubica A; Navarese EP; Kubica J
Kardiol Pol; 2012; 70(10):1053-60. PubMed ID: 23080100
[No Abstract] [Full Text] [Related]
15. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
[TBL] [Abstract][Full Text] [Related]
16. Dabigatran and postmarketing reports of bleeding.
Southworth MR; Reichman ME; Unger EF
N Engl J Med; 2013 Apr; 368(14):1272-4. PubMed ID: 23484796
[No Abstract] [Full Text] [Related]
17. Avoiding adverse events with dabigatran by careful selection of eligible patients.
Baker RI; Harper P; McLintock C
Med J Aust; 2012 Apr; 196(7):431-2. PubMed ID: 22509863
[No Abstract] [Full Text] [Related]
18. Intensity and quality of warfarin anticoagulation in Chinese patients: setting the record straight.
Eikelboom JW; Hart RG
Stroke; 2015 Jan; 46(1):5-6. PubMed ID: 25406147
[No Abstract] [Full Text] [Related]
19. Cost-effectiveness of new oral anticoagulants compared with warfarin in preventing stroke and other cardiovascular events in patients with atrial fibrillation.
Coyle D; Coyle K; Cameron C; Lee K; Kelly S; Steiner S; Wells GA
Value Health; 2013 Jun; 16(4):498-506. PubMed ID: 23796283
[TBL] [Abstract][Full Text] [Related]
20. Dabigatran - neurosurgical anathema?
Thomas PA; Schaerf NB; Rosenfeld JV
Med J Aust; 2013 Aug; 199(4):238-40. PubMed ID: 23984772
[No Abstract] [Full Text] [Related]
[Next] [New Search]
